share_log

Morgan Stanley Maintains Equal-Weight on NeuroPace, Raises Price Target to $9

Benzinga ·  Dec 4, 2023 07:43

Morgan Stanley analyst Drew Ranieri maintains NeuroPace (NASDAQ:NPCE) with a Equal-Weight and raises the price target from $8 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment